Elevance Health/$ELV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Elevance Health
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Ticker
$ELV
Sector
Primary listing
NYSE
Employees
104,200
Headquarters
Website
Elevance Health Metrics
BasicAdvanced
$76B
13.56
$25.21
-
$6.84
2.00%
Price and volume
Market cap
$76B
52-week high
$458.75
52-week low
$273.71
Average daily volume
1.6M
Dividend rate
$6.84
Financial strength
Current ratio
1.535
Quick ratio
1.405
Long term debt to equity
69.952
Total debt to equity
72.789
Dividend payout ratio (TTM)
27.00%
Interest coverage (TTM)
5.79%
Profitability
EBITDA (TTM)
9,658
Gross margin (TTM)
25.56%
Net profit margin (TTM)
2.84%
Operating margin (TTM)
4.07%
Effective tax rate (TTM)
15.63%
Revenue per employee (TTM)
$1,910,000
Management effectiveness
Return on assets (TTM)
4.25%
Return on equity (TTM)
13.25%
Valuation
Price to earnings (TTM)
13.56
Price to revenue (TTM)
0.386
Price to book
1.73
Price to tangible book (TTM)
17.48
Price to free cash flow (TTM)
24.19
Free cash flow yield (TTM)
4.13%
Free cash flow per share (TTM)
14.132
Dividend yield (TTM)
2.00%
Forward dividend yield
2.00%
Growth
Revenue change (TTM)
12.62%
Earnings per share change (TTM)
-1.83%
3-year revenue growth (CAGR)
8.34%
10-year revenue growth (CAGR)
9.66%
3-year earnings per share growth (CAGR)
1.26%
10-year earnings per share growth (CAGR)
10.39%
What the Analysts think about Elevance Health
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Elevance Health Financial Performance
Revenues and expenses
Elevance Health Earnings Performance
Company profitability
Elevance Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Elevance Health stock?
Elevance Health (ELV) has a market cap of $76B as of January 29, 2026.
What is the P/E ratio for Elevance Health stock?
The price to earnings (P/E) ratio for Elevance Health (ELV) stock is 13.56 as of January 29, 2026.
Does Elevance Health stock pay dividends?
Yes, the Elevance Health (ELV) stock pays dividends to shareholders. As of January 29, 2026, the dividend rate is $6.84 and the yield is 2%. Elevance Health has a payout ratio of 27% on a trailing twelve-month basis.
When is the next Elevance Health dividend payment date?
The next Elevance Health (ELV) dividend payment is scheduled for March 25, 2026.
What is the beta indicator for Elevance Health?
Elevance Health (ELV) does not currently have a Beta indicator.